STORM in the News
Mike Leviten speaks to Oliver Rausch and Hendrik Weisser about STORM’s algorithm to extend the use of mass spectrometry data to RNA epigenetics
Read more
John Hodgson speaks to Tony Kouzarides about why RNA epigenetics is an exciting area to invest in
Read more
Virginia Li talks to Hakan Goker, M Ventures about STORM Therapeutics and investing in RNA
Read more
Thomas Meek talks to CEO Keith Blundy about STORM Therapeutics and the untapped RNA space
Read more
Keith Blundy, CEO of STORM Therapeutics, discusses the company’s founding and upcoming milestones.
Read more